Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay

被引:0
作者
Eliana Baez-Jurado
Gina Guio Vega
Gjumrakch Aliev
Vadim V. Tarasov
Paula Esquinas
Valentina Echeverria
George E. Barreto
机构
[1] Pontificia Universidad Javeriana,Departamento de Nutrición y Bioquímica, Facultad de Ciencias
[2] Institute of Physiologically Active Compounds Russian Academy of Sciences,School of Health Science and Healthcare Administration
[3] GALLY International Biomedical Research Consulting LLC,Institute of Pharmacy and Translational Medicine
[4] University of Atlanta,Facultad Medicina Veterinaria y Zootecnia
[5] Sechenov First Moscow State Medical University,Facultad Ciencias de la Salud
[6] Universidad Nacional de Colombia,Instituto de Ciencias Biomédicas
[7] Universidad San Sebastián,undefined
[8] Universidad Autónoma de Chile,undefined
来源
Molecular Neurobiology | 2018年 / 55卷
关键词
Astrocytes; assay; Mesenchymal stem cells; Conditioned medium; Adipose tissue; Neuroglobin;
D O I
暂无
中图分类号
学科分类号
摘要
Previous studies have indicated that paracrine factors (conditioned medium) increase wound closure and reduce reactive oxygen species in a traumatic brain injury in vitro model. Although the beneficial effects of conditioned medium from human adipose tissue-derived mesenchymal stem cells (hMSCA-CM) have been previously suggested for various neurological diseases, their actions on astrocytic cells are not well understood. In this study, we have explored the effect of hMSCA-CM on human astrocyte model (T98G cells) subjected to scratch assay. Our results indicated that hMSCA-CM improved cell viability, reduced nuclear fragmentation, attenuated the production of reactive oxygen species, and preserved mitochondrial membrane potential and ultrastructural parameters. In addition, hMSCA-CM upregulated neuroglobin in T98G cells and the genetic silencing of this protein prevented the protective action of hMSCA-CM on damaged cells, suggesting that neuroglobin is mediating, at least in part, the protective effect of hMSCA-CM. Overall, this evidence suggests that the use of hMSCA-CM is a promising therapeutic strategy for the protection of astrocytic cells in central nervous system (CNS) pathologies.
引用
收藏
页码:2285 / 2300
页数:15
相关论文
共 154 条
[1]  
Wei X(2013)Mesenchymal stem cells: a new trend for cell therapy Acta Pharmacol Sin 34 747-754
[2]  
Toma C(2002)Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 93-98
[3]  
Guerit D(2014)FOXO3A regulation by miRNA-29a controls chondrogenic differentiation of mesenchymal stem cells and cartilage formation Stem Cells Dev 23 1195-1205
[4]  
Oswald J(2004)Mesenchymal stem cells can be differentiated into endothelial cells in vitro Stem Cells 22 377-384
[5]  
Gnecchi M(2016)Paracrine mechanisms of mesenchymal stem cells in tissue repair Methods Mol Biol 1416 123-146
[6]  
Huang B(2016)Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively J Transl Med 14 45-846
[7]  
Hwang B(2016)Pretreatment with bone marrow-derived mesenchymal stromal cell-conditioned media confers pulmonary ischemic tolerance J Thorac Cardiovasc Surg 151 841-1083
[8]  
Lee JC(2016)Notice of retraction: therapeutic effects of umbilical cord blood derived mesenchymal stem cell-conditioned medium on pulmonary arterial hypertension in rats J Pathol Transl Med 50 325-e1131
[9]  
Pires AO(2016)Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis Stem Cells Dev 25 1073-2211
[10]  
Pischiutta F(2016)Protection of brain injury by amniotic mesenchymal stromal cell-secreted metabolites Crit Care Med 44 e1118-709